GlaxoSmithKline Enterprise Account Executive Salaries in Wilmington, DE
The average GlaxoSmithKline Enterprise Account Executive in Wilmington, DE earns an estimated $115,988 annually, which includes an estimated base salary of $88,945 with a $27,043 bonus. GlaxoSmithKline's Enterprise Account Executive compensation is $2,514 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at GlaxoSmithKline in Wilmington, DE can range from $52,000 - $205,000.
In Wilmington, DE, The Business Development Department at GlaxoSmithKline earns $1,806 more on average than the Marketing Department.
Last updated 2 years ago.
- $88,945
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at GlaxoSmithKline
In Wilmington, DE, Enterprise Account Executives earn $1,373 more than Account Managers, and $40,547 less than Business Development Managers.
Compensation at GlaxoSmithKline by Department
In Wilmington, DE, The Business Development Department averages $1,806 more than the Marketing Department, and $3,199 less than the Engineering Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to GlaxoSmithKline reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to GlaxoSmithKline reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at GlaxoSmithKline Rate Their Compensation
The majority of Enterprise Account Executives at GlaxoSmithKline believe they're compensated fairly. 100% of Enterprise Account Executives at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
